Flavokawain B inhibits NF-κB inflammatory signaling pathway activation in inflammatory bowel disease by targeting TLR2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Flavokawain B inhibits NF-κB inflammatory signaling pathway activation in inflammatory bowel disease by targeting TLR2

Published:2024-05 Issue: Volume:486 Page:116922
ISSN:0041-008X
Container-title:Toxicology and Applied Pharmacology
language:en
Short-container-title:Toxicology and Applied Pharmacology

Author:

Chen Yi,Jin Tianyang,Zhang Mengpei,Hong Bo,Jin Bo,Hu Chenghong,Wang Jiong,Chen Yue,Zhang Lingxi,Wang Yi,Huang Lijiang

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference47 articles.

1. Flavokawain B induces apoptosis of non-small cell lung cancer H460 cells via Bax-initiated mitochondrial and JNK pathway;An;Biotechnol. Lett.,2012

2. TLR2-MyD88-NF-κB pathway is involved in tubulointerstitial inflammation caused by proteinuria;Ding;Int. J. Biochem. Cell Biol.,2015

3. Selective targeting of the TLR2/MyD88/NF-κB pathway reduces α-synuclein spreading in vitro and in vivo;Dutta;Nat. Commun.,2021

4. Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency;Egger;Digestion,2000

5. Expression of toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis;Frolova;J. Histochem. Cytochem.,2008

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Treatments, Emerging Therapeutics, and Natural Remedies for Inflammatory Bowel Disease;Molecules;2024-08-21

2. Multi-Drug Resistance and Breast Cancer Progression via Toll-Like Receptors (TLRs) Signaling;Cell Biochemistry and Biophysics;2024-08-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3